Compare KLTR & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KLTR | ACB |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Pharmaceuticals and Biotechnology |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.0M | 232.3M |
| IPO Year | 2021 | 2016 |
| Metric | KLTR | ACB |
|---|---|---|
| Price | $1.38 | $3.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | 210.6K | ★ 963.0K |
| Earning Date | 05-08-2026 | 06-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $180,854,000.00 | N/A |
| Revenue This Year | $2.96 | $6.31 |
| Revenue Next Year | $4.96 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.20 | N/A |
| 52 Week Low | $1.06 | $2.56 |
| 52 Week High | $2.05 | $6.67 |
| Indicator | KLTR | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 35.77 | 59.47 |
| Support Level | $1.32 | $3.68 |
| Resistance Level | $1.53 | $3.91 |
| Average True Range (ATR) | 0.05 | 0.13 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 2.27 | 40.43 |
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.